Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-02 Purchase | 2021-06-04 4:06 pm | Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer | 6,250 | $4.028 | $25,175 | 6,250 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-27 8:37 pm | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 17,500 | $4.1026 | $71,795 | 861,250 (Indirect Direct) | View |
| 2021-02-12 Purchase | 2021-02-12 6:00 pm | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 1,000 | $8 | $8,000 | 16,686 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-22 Option Award | 2023-09-26 4:08 pm | N/A 2033-09-22 | GRI BIO Inc. | GRI | Kelly Leanne Chief Financial Officer | 83,333 | $1.52 | 83,333 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:10 pm | N/A 2033-08-10 | GRI BIO Inc. | GRI | Szekeres David Leslie Director | 34,483 | $2.9 | 34,483 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:07 pm | N/A 2033-08-10 | GRI BIO Inc. | GRI | SIMPSON CAMILLA V Director | 34,483 | $2.9 | 34,483 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:07 pm | N/A 2033-08-10 | GRI BIO Inc. | GRI | Rongen Roelof Director | 34,483 | $2.9 | 34,483 (Direct) | View |
| 2023-08-10 Option Award | 2023-08-14 4:06 pm | N/A 2033-08-10 | GRI BIO Inc. | GRI | Baker David Charles Director | 34,483 | $2.9 | 34,483 (Direct) | View |
| 2023-04-21 Option Award | 2023-04-24 6:30 pm | N/A N/A | GRI BIO Inc. | GRI | Hertz Walter Marc Chief Executive Officer 10% Owner | 385,510 | $0 | 385,510 (Direct) | View |
| 2023-04-21 Option Award | 2023-04-24 6:29 pm | N/A N/A | GRI BIO Inc. | GRI | Agro Albert Chief Medical Officer | 172,189 | $0 | 172,189 (Direct) | View |
| 2023-04-21 Option Award | 2023-04-24 6:29 pm | N/A N/A | GRI BIO Inc. | GRI | Chaturvedi Vipin Chief Scientific Officer | 172,189 | $0 | 172,189 (Direct) | View |
| 2022-12-13 Other | 2022-12-15 4:26 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 28,517 | $0 | 38,023 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 2:03 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 38,023 | $0 | 38,023 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 1:32 pm | N/A 2032-06-09 | Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 1:32 pm | N/A 2032-06-09 | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 1:31 pm | N/A 2032-06-09 | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2022-02-23 Option Award | 2022-03-09 5:02 pm | N/A 2032-02-23 | Vallon Pharmaceuticals Inc. | VLON | Chhabra Meenu Director | 15,000 | $7.67 | 15,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-03-01 5:04 pm | N/A 2032-02-15 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 61,000 | $5.63 | 61,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-03-01 5:03 pm | N/A 2032-02-15 | Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer | 50,000 | $5.63 | 50,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:09 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director | 29,286 | $0 | 29,286 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:08 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director | 25,204 | $0 | 25,204 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:08 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Levi Ofir Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:07 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:06 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Toren Penny SVP, Regul Affairs & Prog Mgmt | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:06 pm | N/A 2031-05-14 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-02-12 Other | 2021-02-12 6:02 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director | 47,063 | $6.4 | 94,126 (Indirect) | View |
| 2021-02-12 Other | 2021-02-12 6:02 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | SALMON Pharma GmbH 10% Owner | 47,063 | $6.4 | 94,126 (Direct) | View |
| 2021-02-12 Option Award | 2021-02-12 6:01 pm | N/A 2031-02-12 | Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-02-12 Other | 2021-02-12 6:00 pm | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 7,843 | $6.4 | 16,686 (Direct) | View |
Ownership | 2021-02-10 08:31 am | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director 10% Owner | 0 | $0 | 843,750 (Indirect) | View |
Ownership | 2021-02-10 08:31 am | N/A N/A | Vallon Pharmaceuticals Inc. | VLON | Arcturus Therapeutics Holdings Inc. 10% Owner | 0 | $0 | 843,750 (Direct) | View |
Ownership | 2021-02-09 9:17 pm | 2019-01-15 2028-10-01 | Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer | 0 | $0 | 108,125 (Direct) | View |